BIND THERAPEUTICS INC Inactive Instrument
Company BIND Therapeutics Inc Nasdaq
Equities
US05548N1072
Biotechnology & Medical Research
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
Stephen Zale
CTO | Chief Tech/Sci/R&D Officer | 68 | 31/10/06 |
Tom Baker
IRC | Investor Relations Contact | - | - |
Neil Bander
PRN | Corporate Officer/Principal | - | - |
| Corporate Officer/Principal | - | 23/07/16 | |
James L. Wright
PRN | Corporate Officer/Principal | 76 | 31/12/06 |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Corporate Officer/Principal | - | 23/07/16 |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 20,886,802 | 17,860,424 ( 85.51 %) | 0 | 85.51 % |
Company contact information
DNIB Unwind, Inc.
333 South Grand Avenue Suite 4100
90071, Los Angeles
+617-491-3400
http://bindtherapeutics.com
Sector
| 1st Jan change | Capi. | |
|---|---|---|
| -3.46% | 102B | |
| +1.41% | 96.29B | |
| +2.13% | 22.18B | |
| -15.84% | 21.2B | |
| -9.21% | 18.31B | |
| -39.98% | 17.38B | |
| -14.65% | 16.36B | |
| +4.39% | 13.97B | |
| +31.35% | 12.17B |
